ONCO.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally...

Stats
Today's Volume	56 039.00
Average Volume	286 133
Market Cap	779.41M
EPS	SEK0 ( 2023-11-08 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-3.00
ATR14	SEK0.0560 (0.65%)

Volume Correlation

Long: 0.18 (neutral)

Short: 0.70 (moderate)

Signal:(47.222) Neutral

Oncopeptides AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncopeptides AB (publ) Correlation - Currency/Commodity

0.05
( neutral )

-0.07
( neutral )

0.00
( neutral )

0.18
( neutral )

0.31
( neutral )

0.45
( neutral )

Oncopeptides AB (publ) Financials

Annual	2022
Revenue:	SEK8.36M
Gross Profit:	SEK8.35M (99.93 %)
EPS:	SEK-4.11

Q3	2023
Revenue:	SEK2.81M
Gross Profit:	SEK4.70M (167.59 %)
EPS:	SEK-0.450

Q2	2023
Revenue:	SEK25.95M
Gross Profit:	SEK25.93M (99.90 %)
EPS:	SEK-0.620

Q1	2023
Revenue:	SEK1.12M
Gross Profit:	SEK1.11M (99.02 %)
EPS:	SEK-0.790

Oncopeptides AB (publ)

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.